Clinical Trials List
2008-09-01 - 2009-06-30
Phase III
Terminated14
-
Trial Applicant
Daiichi Sankyo Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 陳世英 Division of Emergency Medicine
- 姚建安 Division of Family Medicine
- 郭斐然 Division of Family Medicine
- Kuo-Chin Huang Division of Family Medicine
- 程劭儀 Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Tsong-Yih Ou Division of Infectious Disease
- 賴銘堂 Division of Otolaryngology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- RONG -SAN JIANG Division of Otolaryngology
- 蔡哲安 Division of Infectious Disease
- 胡松原 Division of Emergency Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 黃信彰 Division of Family Medicine
- Yu-Jiun Chan Division of Infectious Disease
- 顏鴻章 Division of Emergency Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 高志翔 Division of Emergency Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 胡勝川 Division of Emergency Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 黃瑞湘 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 張進富 Division of Emergency Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
300 participants
-
Global
1500 participants
